CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C11304 | BRD-K28138218 | BRD-K28138218 | -- | -- | -- | Details |
| C11305 | BRD-K28139946 | BRD-K28139946 | -- | -- | -- | Details |
| C11306 | BRD-K28140029 | BRD-K28140029 | -- | -- | -- | Details |
| C11307 | BRD-K28140275 | BRD-K28140275 | -- | -- | -- | Details |
| C11308 | BRD-K28143534 | cyproheptadine | HRH1 | Histamine receptor antagonist | -- | Details |
| C11309 | BRD-K28149578 | BRD-K28149578 | -- | -- | -- | Details |
| C11310 | BRD-K28154645 | BRD-K28154645 | -- | -- | -- | Details |
| C11311 | BRD-K28159131 | BRD-K28159131 | -- | -- | -- | Details |
| C11312 | BRD-K28162668 | BRD-K28162668 | -- | -- | -- | Details |
| C11313 | BRD-K28165728 | BRD-K28165728 | -- | -- | -- | Details |
| C11314 | BRD-K28165749 | BRD-K28165749 | -- | -- | -- | Details |
| C11315 | BRD-K28167849 | ichthynone | -- | -- | -- | Details |
| C11316 | BRD-K28168037 | fenretinide | RARA | Apoptosis stimulant; Retinoid receptor agonist | -- | Details |
| C11317 | BRD-K28169522 | BRD-K28169522 | -- | -- | -- | Details |
| C11318 | BRD-K28174705 | BRD-K28174705 | -- | -- | -- | Details |
| C11319 | BRD-K28178212 | GW-441756 | NTRK1 | Growth factor receptor inhibitor | -- | Details |
| C11320 | BRD-K28179362 | BRD-K28179362 | -- | -- | -- | Details |
| C11321 | BRD-K28180706 | BRD-K28180706 | -- | -- | -- | Details |
| C11322 | BRD-K28183345 | proguanil | -- | -- | -- | Details |
| C11323 | BRD-K28184331 | BRD-K28184331 | -- | -- | -- | Details |
| C11324 | BRD-K28184645 | BRD-K28184645 | -- | -- | -- | Details |
| C11325 | BRD-K28185108 | BRD-K28185108 | -- | -- | -- | Details |
| C11326 | BRD-K28187112 | BRD-K28187112 | -- | -- | -- | Details |
| C11327 | BRD-K28190569 | BRD-K28190569 | -- | -- | -- | Details |
| C11328 | BRD-K28192623 | spiradoline | OPRK1 | Opioid receptor agonist | -- | Details |
| C11329 | BRD-K28195874 | BRD-K28195874 | -- | -- | -- | Details |
| C11330 | BRD-K28208028 | BRD-K28208028 | -- | -- | -- | Details |
| C11331 | BRD-K28210218 | cephalothin | -- | -- | -- | Details |
| C11332 | BRD-K28215800 | BRD-K28215800 | -- | -- | -- | Details |
| C11333 | BRD-K28216304 | BRD-K28216304 | -- | -- | -- | Details |
| C11334 | BRD-K28217197 | ganaxolone | -- | -- | -- | Details |
| C11335 | BRD-K28223745 | BRD-K28223745 | -- | -- | -- | Details |
| C11336 | BRD-K28247259 | BRD-K28247259 | -- | -- | -- | Details |
| C11337 | BRD-K28249211 | BRD-K28249211 | -- | -- | -- | Details |
| C11338 | BRD-K28250273 | BRD-K28250273 | -- | -- | -- | Details |
| C11339 | BRD-K28256231 | BRD-K28256231 | -- | -- | -- | Details |
| C11340 | BRD-K28258038 | BRD-K28258038 | -- | -- | -- | Details |
| C11341 | BRD-K28264750 | BRD-K28264750 | -- | -- | -- | Details |
| C11342 | BRD-K28268716 | BRD-K28268716 | -- | -- | -- | Details |
| C11343 | BRD-K28269391 | BRD-K28269391 | -- | -- | -- | Details |
| C11344 | BRD-K28274866 | BRD-K28274866 | -- | -- | -- | Details |
| C11345 | BRD-K28276103 | BRD-K28276103 | -- | -- | -- | Details |
| C11346 | BRD-K28276275 | BRD-K28276275 | -- | -- | -- | Details |
| C11347 | BRD-K28282432 | BRD-K28282432 | -- | -- | -- | Details |
| C11348 | BRD-K28282859 | BRD-K28282859 | -- | -- | -- | Details |
| C11349 | BRD-K28284219 | BRD-K28284219 | -- | -- | -- | Details |
| C11350 | BRD-K28288650 | SA-244587 | -- | -- | -- | Details |
| C11351 | BRD-K28293491 | BRD-K28293491 | -- | -- | -- | Details |
| C11352 | BRD-K28294686 | BRD-K28294686 | -- | -- | -- | Details |
| C11353 | BRD-K28296557 | BRD-K28296557 | -- | -- | AKT-inhibitor-IV | Details |
| C11354 | BRD-K28299335 | BRD-K28299335 | -- | -- | -- | Details |
| C11355 | BRD-K28305165 | BRD-K28305165 | -- | -- | -- | Details |
| C11356 | BRD-K28305693 | BRD-K28305693 | -- | -- | -- | Details |
| C11357 | BRD-K28307902 | flutamide | AR | Androgen receptor antagonist | -- | Details |
| C11358 | BRD-K28308851 | BRD-K28308851 | -- | -- | alpha-methylhistamine-dihydrobromide-(S)-(+) | Details |
| C11359 | BRD-K28312904 | BRD-K28312904 | -- | -- | -- | Details |
| C11360 | BRD-K28314528 | BRD-K28314528 | -- | -- | -- | Details |
| C11361 | BRD-K28317853 | BRD-K28317853 | -- | -- | -- | Details |
| C11362 | BRD-K28319429 | BRD-K28319429 | -- | -- | -- | Details |
| C11363 | BRD-K28320832 | BRD-K28320832 | -- | -- | -- | Details |
| C11364 | BRD-K28329571 | BRD-K28329571 | -- | -- | -- | Details |
| C11365 | BRD-K28336972 | BRD-K28336972 | -- | -- | -- | Details |
| C11366 | BRD-K28339544 | BRD-K28339544 | -- | -- | -- | Details |
| C11367 | BRD-K28344523 | BRD-K28344523 | -- | -- | -- | Details |
| C11368 | BRD-K28346421 | rifapentine | CYP2C8; CYP2C9; CYP3A4 | RNA polymerase inhibitor | -- | Details |
| C11369 | BRD-K28347985 | BRD-K28347985 | -- | -- | -- | Details |
| C11370 | BRD-K28349636 | BRD-K28349636 | -- | -- | -- | Details |
| C11371 | BRD-K28351377 | BRD-K28351377 | -- | -- | -- | Details |
| C11372 | BRD-K28354175 | BRD-K28354175 | -- | -- | -- | Details |
| C11373 | BRD-K28357534 | BRD-K28357534 | -- | -- | -- | Details |
| C11374 | BRD-K28358982 | BRD-K28358982 | -- | -- | -- | Details |
| C11375 | BRD-K28360340 | TW-37 | MCL1; BCL2; BCL2L1 | BCL inhibitor | -- | Details |
| C11376 | BRD-K28362289 | BRD-K28362289 | -- | -- | -- | Details |
| C11377 | BRD-K28366444 | BRD-K28366444 | -- | -- | -- | Details |
| C11378 | BRD-K28366633 | BRD-K28366633 | -- | -- | -- | Details |
| C11379 | BRD-K28370158 | BRD-K28370158 | -- | -- | -- | Details |
| C11380 | BRD-K28372487 | BRD-K28372487 | -- | -- | -- | Details |
| C11381 | BRD-K28375929 | BRD-K28375929 | -- | -- | -- | Details |
| C11382 | BRD-K28377013 | BRD-K28377013 | -- | -- | -- | Details |
| C11383 | BRD-K28377322 | BRD-K28377322 | -- | -- | -- | Details |
| C11384 | BRD-K28391526 | BRD-K28391526 | -- | -- | -- | Details |
| C11385 | BRD-K28392481 | AZD-4547 | -- | -- | -- | Details |
| C11386 | BRD-K28394201 | BRD-K28394201 | -- | -- | -- | Details |
| C11387 | BRD-K28395853 | BRD-K28395853 | -- | -- | -- | Details |
| C11388 | BRD-K28397270 | BRD-K28397270 | -- | -- | -- | Details |
| C11389 | BRD-K28399883 | BRD-K28399883 | -- | -- | -- | Details |
| C11390 | BRD-K28414977 | BRD-K28414977 | -- | -- | -- | Details |
| C11391 | BRD-K28418330 | GSK-343 | -- | -- | -- | Details |
| C11392 | BRD-K28421747 | BRD-K28421747 | -- | -- | -- | Details |
| C11393 | BRD-K28428262 | brivanib | FGFR1; FLT1; KDR | FGFR inhibitor; VEGFR inhibitor | -- | Details |
| C11394 | BRD-K28428448 | SA-427636 | -- | -- | -- | Details |
| C11395 | BRD-K28429328 | BRD-K28429328 | -- | -- | -- | Details |
| C11396 | BRD-K28430035 | BRD-K28430035 | -- | -- | -- | Details |
| C11397 | BRD-K28431278 | BRD-K28431278 | -- | -- | -- | Details |
| C11398 | BRD-K28431554 | BRD-K28431554 | -- | -- | -- | Details |
| C11399 | BRD-K28431799 | BRD-K28431799 | -- | -- | -- | Details |
| C11400 | BRD-K28433302 | BRD-K28433302 | -- | -- | -- | Details |
| C11401 | BRD-K28433349 | BRD-K28433349 | -- | -- | -- | Details |
| C11402 | BRD-K28436871 | BRD-K28436871 | -- | -- | -- | Details |
| C11403 | BRD-K28437309 | BRD-K28437309 | -- | -- | -- | Details |